Free Trial

AtriCure (ATRC) Competitors

AtriCure logo
$31.78 +0.39 (+1.24%)
As of 07/3/2025 01:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ATRC vs. TFX, ITGR, ATEC, IART, OFIX, SRDX, ANGO, ARAY, RMTI, and RSLS

Should you be buying AtriCure stock or one of its competitors? The main competitors of AtriCure include Teleflex (TFX), Integer (ITGR), Alphatec (ATEC), Integra LifeSciences (IART), Orthofix Medical (OFIX), Surmodics (SRDX), AngioDynamics (ANGO), Accuray (ARAY), Rockwell Medical (RMTI), and ReShape Lifesciences (RSLS). These companies are all part of the "health care equipment" industry.

AtriCure vs. Its Competitors

Teleflex (NYSE:TFX) and AtriCure (NASDAQ:ATRC) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, risk, profitability, earnings, dividends, analyst recommendations, valuation and institutional ownership.

In the previous week, Teleflex had 7 more articles in the media than AtriCure. MarketBeat recorded 10 mentions for Teleflex and 3 mentions for AtriCure. Teleflex's average media sentiment score of 0.64 beat AtriCure's score of 0.34 indicating that Teleflex is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Teleflex
5 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
AtriCure
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

95.6% of Teleflex shares are owned by institutional investors. Comparatively, 99.1% of AtriCure shares are owned by institutional investors. 1.4% of Teleflex shares are owned by insiders. Comparatively, 3.5% of AtriCure shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Teleflex has a net margin of 4.96% compared to AtriCure's net margin of -7.95%. Teleflex's return on equity of 14.73% beat AtriCure's return on equity.

Company Net Margins Return on Equity Return on Assets
Teleflex4.96% 14.73% 8.79%
AtriCure -7.95%-5.68%-4.34%

Teleflex has a beta of 1.08, suggesting that its stock price is 8% more volatile than the S&P 500. Comparatively, AtriCure has a beta of 1.56, suggesting that its stock price is 56% more volatile than the S&P 500.

Teleflex currently has a consensus price target of $164.63, indicating a potential upside of 37.30%. AtriCure has a consensus price target of $50.67, indicating a potential upside of 59.43%. Given AtriCure's stronger consensus rating and higher probable upside, analysts clearly believe AtriCure is more favorable than Teleflex.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teleflex
1 Sell rating(s)
8 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.09
AtriCure
0 Sell rating(s)
0 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
3.00

Teleflex has higher revenue and earnings than AtriCure. AtriCure is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teleflex$3.05B1.74$69.68M$3.1737.82
AtriCure$465.31M3.38-$44.70M-$0.81-39.23

Summary

Teleflex beats AtriCure on 9 of the 16 factors compared between the two stocks.

Get AtriCure News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATRC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ATRC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATRC vs. The Competition

MetricAtriCureMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.57B$10.52B$5.56B$9.05B
Dividend YieldN/A2.07%5.24%4.01%
P/E Ratio-39.2317.0327.6120.24
Price / Sales3.3829.54416.87118.48
Price / CashN/A22.9936.8958.10
Price / Book3.363.668.035.67
Net Income-$44.70M$235.40M$3.18B$249.21M
7 Day Performance-1.55%2.15%2.93%3.28%
1 Month Performance-8.86%3.38%3.75%5.55%
1 Year Performance34.26%-10.18%35.20%21.09%

AtriCure Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATRC
AtriCure
3.2979 of 5 stars
$31.78
+1.2%
$50.67
+59.4%
+41.6%$1.57B$465.31M-39.231,300
TFX
Teleflex
4.6399 of 5 stars
$118.21
-1.1%
$164.63
+39.3%
-43.3%$5.28B$3.05B37.2914,100
ITGR
Integer
3.6202 of 5 stars
$122.92
+0.3%
$145.00
+18.0%
+5.2%$4.28B$1.72B58.2611,000
ATEC
Alphatec
4.3443 of 5 stars
$11.10
+0.2%
$17.89
+61.2%
+10.1%$1.62B$611.56M-9.65700
IART
Integra LifeSciences
4.0805 of 5 stars
$12.27
-0.2%
$18.63
+51.8%
-53.1%$955.08M$1.61B-32.294,396
OFIX
Orthofix Medical
3.0725 of 5 stars
$11.15
+0.5%
$21.50
+92.8%
-17.7%$434.52M$799.49M-3.021,616Gap Up
SRDX
Surmodics
4.2001 of 5 stars
$29.71
+3.1%
$43.00
+44.7%
-28.6%$411.96M$126.08M-21.37450News Coverage
Analyst Revision
ANGO
AngioDynamics
3.9801 of 5 stars
$9.92
+1.4%
$14.00
+41.1%
+68.8%$397.14M$303.91M-9.82760Positive News
ARAY
Accuray
3.6312 of 5 stars
$1.37
-0.7%
N/A-17.7%$142.16M$446.55M-27.401,040Positive News
RMTI
Rockwell Medical
4.0799 of 5 stars
$0.85
+7.1%
$4.00
+371.7%
-51.5%$27.07M$101.49M-42.40300
RSLS
ReShape Lifesciences
0.1508 of 5 stars
$2.44
flat
N/A-99.3%$5.82M$8.01M-0.0150

Related Companies and Tools


This page (NASDAQ:ATRC) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners